
Despite Gazyva being the first drug accepted to treat this type of nephropathy, it’s already approved for a host of other conditions.
Pharmaceutical manufacturers, distributors, and pharmacies are gearing up to make fuller use of bar codes to prevent errors along the medication supply chain, according to the first industry-wide survey by the Healthcare Distribution Management Association.






